Verification evidence is still being completed.
PDF / print export
IDT Biologika
Dessau-Rosslau, Germany
- Verified lead
- Dr. Sally Choe
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Co-CEO
- 2026 technical specialization
- Viral Vaccines, Cell and Gene Therapy, and Fill-Finish CDMO
- Review cycle
- May 2026
- Full address
- Am Pharmapark, 06861 Dessau-Rosslau, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official IDT Biologika management page confirming Dr. Sally Choe in the executive leadership team.
- Editorial note
- Commercial vaccine and biologics campus combining aseptic fill-finish, cold-chain release, and multi-suite GMP manufacturing for international programs.
Viral Vaccines, Cell and Gene Therapy, and Fill-Finish CDMO
GMP Manufacturing, Biologics Fill-Finish, FDA / EMA / ANVISA Quality Standards
Commercial vaccine and biologics campus combining aseptic fill-finish, cold-chain release, and multi-suite GMP manufacturing for international programs.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated05 Jun 2026, 01:06
Commercial vaccine and biologics campus combining aseptic fill-finish, cold-chain release, and multi-suite GMP manufacturing for international programs.
Contact & location
- Website
- idt-biologika.com
- Company page
- Lead
- Dr. Sally Choe (verified ↗)
- Compliance
- GMP Manufacturing · FDA / EMA / ANVISA Quality Standards
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Commercial biologics CDMO
- Capabilities
- Viral Vaccine Manufacturing · Cell and Gene Therapy Services · Aseptic Fill-Finish
- Founded
- 1921
- Headcount
- 1001-5000
Clinical profileSTATUS: VERIFIED MARCH 2026
Dr. Sally Choe
Co-CEO
Full addressAm Pharmapark, 06861 Dessau-Rosslau, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official IDT Biologika contact page naming the Dessau-Rosslau site at Am Pharmapark.
Open sourceCommercial biologics CDMO
Dessau-Rosslau, Germany. Viral Vaccines, Cell and Gene Therapy, and Fill-Finish CDMO. Review completed on 14 Mar 2026.
Paul-Ehrlich-Institut (PEI)
GMP Manufacturing, Biologics Fill-Finish, FDA / EMA / ANVISA Quality Standards
Viral Vaccines, Cell and Gene Therapy, and Fill-Finish CDMO
Commercial vaccine and biologics campus combining aseptic fill-finish, cold-chain release, and multi-suite GMP manufacturing for international programs.
Related companies
Editorial note
The current management layer remains dual-lead; the registry keys Dr. Sally Choe as the verified executive anchor for this record.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Viral Vaccine Manufacturing
Cell and Gene Therapy Services
Aseptic Fill-Finish
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Vaccine process suites
Aseptic filling lines
Cold-chain release laboratories
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is IDT Biologika located?
- IDT Biologika operates from Am Pharmapark, 06861 Dessau-Rosslau, Germany, Dessau-Rosslau, Germany.
- Who runs IDT Biologika?
- IDT Biologika is led by Dr. Sally Choe, Co-CEO. Verified 14 Mar 2026.
- What certifications does IDT Biologika hold?
- IDT Biologika is documented under GMP Manufacturing, FDA / EMA / ANVISA Quality Standards.
- What does IDT Biologika do?
- Commercial vaccine and biologics campus combining aseptic fill-finish, cold-chain release, and multi-suite GMP manufacturing for international programs. Core capabilities: Viral Vaccine Manufacturing, Cell and Gene Therapy Services, Aseptic Fill-Finish.
Editorial context
Related technical briefs
Briefs that name Dessau-Rosslau as a covered market or city.